STOCK TITAN

AMETEK Announces Appointment of Karleen Oberton to Board of Directors

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
management

BERWYN, Pa., Feb. 11, 2021 /PRNewswire/ -- AMETEK, Inc. (NYSE: AME) today announced that its Board of Directors has appointed Karleen Oberton as a new director of the Company. Ms. Oberton serves as Chief Financial Officer of Hologic, Inc. (NASDAQ: HOLX), an innovative medical technology company primarily focused on improving women's health and well-being through early detection and treatment systems.

"We are pleased to welcome Karleen to AMETEK as a member of our Board of Directors," commented David A. Zapico, AMETEK Chairman and Chief Executive Officer. "Karleen is a skilled business executive with more than 30 years of experience in public accounting, biotechnology and medical device manufacturing. Her strong financial acumen along with her proven executive leadership managing global organizations nicely complements our existing Board skill set."

Joining Hologic as Vice President and Corporate Controller in 2006, Ms. Oberton has since held roles of increasing responsibility within the company's finance function. In 2014, she was named Corporate Vice President and Chief Accounting Officer and in 2018 was elected Chief Financial Officer. Prior to joining Hologic, Ms. Oberton served as Senior Corporate Controller for ImmunoGen, a biotechnology company developing targeted anticancer therapeutics. Earlier in her career, Ms. Oberton held leadership positions at Ernst & Young and Arthur Andersen.

Ms. Oberton holds a bachelor's degree in Business Administration from Merrimack College and was an active Certified Public Accountant for more than 18 years.

Corporate Profile
AMETEK is a leading global manufacturer of electronic instruments and electromechanical devices with 2020 sales of more than $4.5 billion. The AMETEK Growth Model integrates the Four Growth Strategies - Operational Excellence, New Product Development, Global and Market Expansion, and Strategic Acquisitions - with a disciplined focus on cash generation and capital deployment. AMETEK's objective is double-digit percentage growth in earnings per share over the business cycle and a superior return on total capital. The common stock of AMETEK is a component of the S&P 500.

Contact:
AMETEK, Inc.
Kevin Coleman
Vice President, Investor Relations
1100 Cassatt Road
Berwyn, Pennsylvania 19312
kevin.coleman@ametek.com
Phone: 610.889.5247

 

Cision View original content:http://www.prnewswire.com/news-releases/ametek-announces-appointment-of-karleen-oberton-to-board-of-directors-301226467.html

SOURCE AMETEK, Inc.

Ametek Inc

NYSE:AME

AME Rankings

AME Latest News

AME Stock Data

Instruments and Related Products Manufacturing for Measuring, Displaying, and Controlling Industrial Process Variables
Manufacturing
Link
Producer Manufacturing, Miscellaneous Manufacturing, Electrical Products, Manufacturing, Motor and Generator Manufacturing
US
Berwyn

About AME

ametek is a global leader in electronic instruments and electromechanical devices with annual sales of $4.0b. we have approximately 15,000 colleagues at over 120 manufacturing locations with 100 sales and service locations in more than 30 other countries. ametek has a track record of exceptional financial and market success, and our vision is to double the size and profitability of the company within the next five years. ametek's corporate growth plan is based on four key strategies: operational excellence strategic acquisitions & alliances global & market expansion new products ametek colleagues worldwide are committed to our success. through their hard work and dedication, we will achieve our vision for ametek. for more information on ametek career opportunities, visit our web page below.